- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Watson Pharmaceuticals | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
WATSON PHARMACEUTICALS INC.
Watson Pharmaceuticals, Inc. is a pharmaceutical company primarily engaged in the development, production, marketing and distribution of both branded and off-patent pharmaceutical products. The company's branded pharmaceutical business operates primarily in three specialty areas: Dermatology, Women's Health and General Products. The company's products include therapeutic and preventive agents generally sold by prescription or over-the-counter for the treatment of human diseases and disorders.
|
|
| Symbol: |
WPI |
| Exchange(s): |
New York Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
2,535,500
|
2,496,650
|
1,979,240
|
15.49
|
|
Earnings before Interest & Tax ($000)
|
386,490
|
268,750
|
-388,860
|
18.22
|
|
Profit/Loss ($000)
|
238,370
|
141,030
|
-445,000
|
19.92
|
|
Earnings per Share
|
2.09
|
1.27
|
-4.37
|
19.98
|
|
Total Assets ($000)
|
3,677,880
|
3,472,020
|
3,760,570
|
6.09
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
12.05
|
7.99
|
-23.52
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
2,535,500
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
238,380
|
N/A
|
|
Earnings per Share
|
N/A
|
2.10
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
106,140,000
|
104,610,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Paul M. Bisaro, Presi.; C.E.O. |
| CFO: Mark W. Durand, Sr. V.P.; C.F.O. |
| |
| Contact Information |
| Address: |
311 Bonnie Circle,
Corona,
CA,
92880-2 |
Phone: |
951-493-5300 |
| Fax: |
951-493-5836 |
| Web Address: |
www.watsonpharm.com |
| E-Mail : |
info@watson.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
WPI-N
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
